Total Voting Rights
Cairn Homes plc
Total Voting Rights
Dublin/London, 1 April 2020: In conformity with Regulation 20 of the Transparency (Directive 2004/109/EC) Regulations 2007, (as amended) Cairn Homes plc (the "Company") (Euronext Dublin/LSE: CRN) confirms that the total number of Ordinary Shares of €0.001 each in issue as at 1 April 2020 was 749,334,063. Each Ordinary Share carries one vote, therefore the total number of voting rights is 749,334,063. The Company does not hold any Ordinary Shares in treasury.
The figure which may be used by shareholders as a denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the Transparency (Directive 2004/109/EC) Regulations 2007, (as amended) and the Central Bank (Investment Market Conduct) Rules is 749,334,063.
For further information, contact:
Cairn Homes plc +353 1 696 4600
Tara Grimley, Company Secretary
Notes to Editors
Cairn is the leading Irish homebuilder committed to building high-quality, competitively priced, sustainable new homes in great locations. At Cairn, the homeowner is at the very centre of the design process and we strive to provide an unparalleled customer service throughout each stage of the home-buying journey. A new Cairn home is thoughtfully designed and built to last with a focus on creating shared spaces and environments where communities prosper. Cairn owns a c. 17,000 unit land bank across 35 residential development sites, over 90% of which are located in the Greater Dublin Area ("GDA") with excellent public transport and infrastructure links. Cairn is today building on 16 sites in the GDA, which will deliver over 6,750 new homes.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.